Geode Capital Management, LLC Actinium Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 686,153 shares of ATNM stock, worth $967,475. This represents 0.0% of its overall portfolio holdings.

Number of Shares

686,153

Previous 666,310 2.98%

Holding current value

$967,475

Previous $4.93 Million 73.85%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1.72 - $8.0 $34,129 - $158,744	19,843 Added 2.98%	686,153 $1.29 Million
Q2 2024 Aug 09, 2024	BUY	$6.56 - $9.89 $463,070 - $698,135	70,590 Added 11.85%	666,310 $4.93 Million
Q1 2024 May 13, 2024	BUY	$5.0 - $9.2 $130,855 - $240,773	26,171 Added 4.6%	595,720 $4.66 Million
Q4 2023 Feb 13, 2024	BUY	$4.02 - $6.08 $108,982 - $164,828	27,110 Added 5.0%	569,549 $2.89 Million
Q3 2023 Nov 13, 2023	BUY	$5.91 - $7.37 $124,452 - $155,197	21,058 Added 4.04%	542,439 $3.21 Million
Q2 2023 Aug 11, 2023	BUY	$7.15 - $9.39 $2.07 Million - $2.71 Million	288,949 Added 124.32%	521,381 $3.87 Million
Q1 2023 May 15, 2023	BUY	$8.51 - $14.26 $6,348 - $10,637	746 Added 0.32%	232,432 $2.2 Million
Q4 2022 Feb 13, 2023	BUY	$7.05 - $14.41 $123,516 - $252,463	17,520 Added 8.18%	231,686 $2.47 Million
Q3 2022 Nov 14, 2022	BUY	$4.81 - $8.48 $201,774 - $355,727	41,949 Added 24.36%	214,166 $1.58 Million
Q2 2022 Aug 12, 2022	BUY	$4.71 - $7.11 $23,761 - $35,869	5,045 Added 3.02%	172,217 $828,000
Q3 2021 Nov 12, 2021	BUY	$5.76 - $9.67 $83,485 - $140,156	14,494 Added 9.49%	167,172 $1.48 Million
Q2 2021 Aug 13, 2021	BUY	$7.01 - $8.63 $370,632 - $456,285	52,872 Added 52.97%	152,678 $1.21 Million
Q3 2020 Nov 13, 2020	BUY	$7.26 - $18.0 $724,591 - $1.8 Million	99,806 New	99,806 $967,000

Others Institutions Holding ATNM

# of Institutions

Shares Held

8.32M

Call Options Held

65.2K

Put Options Held

21.7K

View Full List

About Actinium Pharmaceuticals, Inc.

Ticker ATNM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,184,700
Market Cap $35.5M
Description
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...

More about ATNM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Actinium Pharmaceuticals, Inc. Transaction History